At the end of this month, on Tuesday, September 29, at 8:00-9:30 p.m. Eastern time (to be precise), there will be a second webinar in the series on the role of active surveillance in the management of favorable-risk forms of localized prostate cancer, coordinated by our good friend Howard Wolinsky and others.
This second webinar will feature Brian Helfand, MD, PhD, talking about the roles of genetic and genomic testing in making decisions about whether particular patients are good candidates for starting on active surveillance and staying on it over time.
To sign up for this webinar, please click here. You can see more information about this upcoming webinar below, and find a link to the first webinar in the series, featuring Peter Carroll, MD.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, genetics, genomics, Helfand, surveillance, webinar |
THE "NEW" PROSTATE CANCER INFOLINK 
Hello Mike.
A long time ago, we corresponded about my book “Ripped Out”. You were kind enough to inform others of its existence.
By the by, I remain cancer free, and otherwise well. I hope you are also.
Recently, a friend of mine ‘got’ cancer (I hate that #@%&!! word) and is currently undergoing treatment. He is, among many other talents, a singer and song writer.
He has written two songs — one mostly funny and another one, mostly angry. I think they are excellent, and if you are interested, I would like to forward them to you. Pplease forward the address you would like me to send them.
If you agree that men would find them of value, please forward them on.
I watch your wonderful and terrible country coping with the biggest and most important experiment in democracy that the world has seen. I wish you and your fellow citizens the very best.
Bill
Website billmartin.net
Tx Mike …
Onward & upwards, Rick
It’s been rescheduled for 7:00 due to the Presidental debate.